Abstract
Opinion on Adaptive Designs in Clinical Trials
Highlights
Opinion on Adaptive Designs in Clinical Trials
Starting from a couple of research papers in this type published in Europe’s peer-reviewed statistical journals, adaptive designs have made much progress in the development and implementation in the past 20 years, which are anticipated to increase the information value of clinical trial data in order to enable better decisions during the course and speed up the development process in the context of fierce competition and limited trial budgets
Phase II dose finding studies were often designed using a small number of doses and a narrow dose-range, focusing on the upper end of the dose–response relationship
Summary
Opinion on Adaptive Designs in Clinical Trials Starting from a couple of research papers in this type published in Europe’s peer-reviewed statistical journals, adaptive designs have made much progress in the development and implementation in the past 20 years, which are anticipated to increase the information value of clinical trial data in order to enable better decisions during the course and speed up the development process in the context of fierce competition and limited trial budgets.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
